Abstract
Utility of Targeted Neurocognitive Testing in Detecting Early Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) after CAR T-Cell Therapy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have